FDA Approves Moderna's mRNA Flu Vaccine.
The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA seasonal flu vaccine, mFLUSIVA.
As featured on
The FDA has approved Moderna's flu vaccine for people aged 50 and older, marking the first approval of a messenger RNA-based vaccine for seasonal flu.
